This article was reviewed by Knox Beasley, MD. If you’ve noticed the signs of male pattern baldness — say, a thinning hairline or a bald patch on the crown of your head — a hormone called DHT is ...

There’s a secret hormone wreaking havoc on your hair, and it’s also one of the biggest contributors to hair loss and thinning. Dihydrotestosterone (DHT) is a hormone that causes hair loss by locking ...

CLEVELAND, March 30, 2026 (GLOBE NEWSWIRE)-- For the estimated 80 million Americans living with androgenic alopecia, genetic hair loss driven by a hormone called DHT, the treatment options have ...

We walk you through one of the biggest ranges of hair loss products on the market.

This article was reviewed by Knox Beasley, MD. Switching from finasteride to dutasteride may help if you’re not seeing enough improvement in hair loss. Dutasteride isn’t FDA-approved for hair loss, ...

Add Yahoo as a preferred source to see more of our stories on Google. I always knew postpartum hair loss was a possibility, but nothing prepared me for the emotional rollercoaster that came with it.

Inner Balance, the women’s health brand founded by Dr. Sarah Daccarett, proudly announces the release of BodyMatched™ Anti-Aging Face Cream + Finasteride; a prescription-strength anti-aging cream ...

After months of hair loss and trying numerous products to fix it, one woman finally found something to help stop the shedding. They key? Pumpkin seed oil. Featured Video TikTok user Emily May ...

With new research by the National Council on Aging affirming the fact that hair loss is not only a problem that faces 85% of men but also 33% of women as they age—and with further research published ...

Life is full of abbreviations. We could rattle off dozens. But one you may not be as readily familiar with is DHT. It's short for dihydrotestosterone, and if you know anything about hair loss, you ...

HairSmart is ending an era of pharmaceutical dependency for genetic hair loss with a Natural DHT blocker, a drug-free protocol, without side effects. Proven across multiple trials CLEVELAND, March 30, ...